Canakinumab Subcutaneous and Cyanocobalamin (B12) Extended-Release Tablets
Determining the interaction of Canakinumab Subcutaneous and Cyanocobalamin (B12) Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: cyanocobalamin
Brand name: Cobolin-M, Depo-Cobolin, Vitamin B12, B-12 Dots, Nascobal, Cobal 1000, Vitamin B-12
Synonyms: Vitamin B12 Injection, Cyanocobalamin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Cyanocobalamin (B12) Injection
- Canakinumab Subcutaneous-Cyanocobalamin (B12) Liquid
- Canakinumab Subcutaneous-Cyanocobalamin (B12) Lozenge and Oral-Disintegrating Tablet (ODT)
- Canakinumab Subcutaneous-Cyanocobalamin (B12) Nasal Spray
- Canakinumab Subcutaneous-Cyanocobalamin (B12) Sublingual Spray
- Canakinumab Subcutaneous-Cyanocobalamin (B12) Sublingual Tablets
- Cyanocobalamin (B12) Extended-Release Tablets-Canasa
- Cyanocobalamin (B12) Extended-Release Tablets-Canasa Pac rectal
- Cyanocobalamin (B12) Extended-Release Tablets-Canasa rectal
- Cyanocobalamin (B12) Extended-Release Tablets-Cancidas
- Cyanocobalamin (B12) Extended-Release Tablets-Candesartan
- Cyanocobalamin (B12) Extended-Release Tablets-Candesartan and Hydrochlorothiazide